{
    "Ingredient": "SAXAGLIPTIN HYDROCHLORIDE",
    "DF;Route": "TABLET;ORAL",
    "Trade_Name": "ONGLYZA",
    "Applicant": "ASTRAZENECA AB",
    "Strength": "EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",
    "Appl_Type": "N",
    "Appl_No": 22350,
    "Product_No": 2,
    "TE_Code": null,
    "Approval_Date": "Jul 31, 2009",
    "RLD": "Yes",
    "RS": "No",
    "Type": "DISCN",
    "Applicant_Full_Name": "ASTRAZENECA AB"
}